We are monitoring the impact of COVID-19 on Latin America Cancer Biomarkers Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2150
Share on
Share on

Latin America Cancer Biomarkers Market Research Report – Segmented By Disease, Services, Application, Type, Profiling Technologies, Country (Brazil, Mexico, Chile, Argentina and Rest of the Latin America) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2150
Pages: 145

Latin America Cancer Biomarkers Market Size (2021 to 2026)

The size of the Cancer Biomarkers Market in Latin America was worth USD 1.29 billion in 2021 and estimated to be growing at a CAGR of 11.52%, to reach USD 2.23 billion by 2026.

Factors such as driving the Latin American cancer biomarkers market expansion include increasing cancer incidence as biomarkers, aiding regulators and developers in making better decisions, and non-invasive technologies that minimize the risk of damaging the human body by reducing the number and size of incisions made during surgery. Biomarkers can also help regulators and developers make better judgments. In addition, the cancer biomarkers market in the Latin American region is expected to grow due to a rise in demand in low- and middle-income countries with a higher acceptance of the treatment.

Furthermore, the increased use of biomarkers in drug development will aid in the selection of the most promising treatment candidates, decreasing the cost of discovery and the chance of failure. This reduces the risk of complications as well as injury to surrounding muscle and tissue. Moreover, people are becoming more aware of cancer biomarkers, the necessity of early detection, and what preventative measures they should take, which positively influences the market growth. Also, these biomarkers help in molecular or genetic testing that can identify a biomarker in cancer that tells doctors what causes the disease to grow and spread, allowing them to choose the most effective therapy for the patient.

However, concerns associated with the reimbursement and unfavorable policies by corporate and public organizations are key challenging factors restricting the market growth. In addition, due to the poor acceptability of sophisticated biomarker testing and the high expense of research and validation due to the longer time required in the research and approval procedure as capital costs rise, these tests are limiting the market growth of the cancer biomarkers. On the other hand, the lack of awareness in rural regions about cancer biomarker treatment techniques and drugs and the need for fast processing impede the market growth of cancer biomarkers.

This research report on the Latin American Cancer Biomarkers Market segmented and sub-segmented into the following categories:

By Disease: 

  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Other Cancers

By Services: 

  • Sample Preparation
  • Assay Development
  • Biomarkers Validation
  • Testing

By Application: 

  • Risk Assessment
  • Development of Molecular Diagnostics
  • Disease Diagnosis
  • Drug Discovery & Development
  • Drug Formulation

By Type: 

  • Protein Biomarkers
  • Genetic Biomarkers
  • Other Biomarkers

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

The Mexican cancer biomarkers market is expected to lead the Latin America region during the forecast period based on the region. The growing number of cancer cases and the increasing concentration of the key players of the pharmaceutical industries are likely to promote the market in Mexico. Growing collaborations and acquisitions are more in this country, which is additionally accelerating the market.

The Brazilian cancer biomarkers market is predicted to grow at the highest CAGR during the forecast period. Factors like technological advancements for the new novel discovery and the development of new therapeutics are influencing the market.

KEY MARKET PLAYERS:

Companies such as Abbott Laboratories, Agendia Bv, Biocurex Inc, Biomerieux S.A., Biomoda Inc, Astellas Pharma Us Inc, Correlogic Systems Inc, Beckman Coulter Inc, Becton, Dickinson And Company, Clarient Inc, Diadexus Inc, Ambrilia Biopharma, Affymetrix Inc and Aureon Laboratories Inc. are playing a dominant role in the LATAM Cancer Biomarkers Market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Disease
      1. Introduction
      2. Prostate Cancer
      3. Breast Cancer
      4. Lung Cancer
      5. Colorectal Cancer
      6. Cervical Cancer
      7. Other Cancer
      8.   Y-o-Y Growth Analysis, By Disease
      9.   Market Attractiveness Analysis, By Disease
      10.   Market Share Analysis, By Disease
    2. By Application
      1. Introduction
      2. Risk Assessment
      3. Development of molecular diagnostics
      4. Disease diagnosis
      5. Drug discovery
      6. Development and Drug formulation
      7. Y-o-Y Growth Analysis, By Application
      8. Market Attractiveness Analysis, By Application
      9. Market Share Analysis, By Application
    3. By Services
      1. Sample Preparation
      2. Assay development
      3. Biomarkers validation and testing
      4. Y-o-Y Growth Analysis, By Services
      5. Market Attractiveness Analysis, By Services
      6. Market Share Analysis, By Services
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Disease
        3. By Services
        4. By Application
        5. By Type
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Disease
        3. By Services
        4. By Application
        5. By Type
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Disease
        3. By Services
        4. By Application
        5. By Type
    2. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Chile
      5. Rest of Latin America
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Abbott Laboratories
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Agendia Bv
    3. Biocurex Inc.
    4. Biomerieux S.A
    5. Biomoda Inc.
    6. Astellas Pharma Us Inc.
    7. Correlogic Systems Inc.
    8. Beckman Coulter Inc.
    9. Becton Dickinson and Company
    10. Clarient Inc.
    11. Diadexus Inc.
    12. Ambrilia Biopharma
    13. Affymetrix Inc.
    14. Aureon Laboratories Inc.
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables

List of Figures

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Cancer Biomarkers Market, By Disease, From 2021 to 2026 (USD Million)
  2. Latin America Prostate Cancer Market, By Region, From 2021 to 2026 (USD Million)
  3. Latin America Breast Cancer Market, By Region, From 2021 to 2026 (USD Million)
  4. Latin America Lung Cancer Market, By Region, From 2021 to 2026 (USD Million)
  5. Latin America Colorectal Cancer Market, By Region, From 2021 to 2026 (USD Million)
  6. Latin America Cervical Cancer  Market, By Region, From 2021 to 2026 (USD Million)
  7. Latin America Other Cancers Market, By Region, From 2021 to 2026 (USD Million)
  8. Latin America Cancer Biomarkers Market, By Services, From 2021 to 2026 (USD Million)
  9. Latin America Sample Preparation Market, By Region, From 2021 to 2026 (USD Million)
  10. Latin America Assay development  Market, By Region, From 2021 to 2026 (USD Million)
  11. Latin America Biomarkers validation and testing Market, By Region, From 2021 to 2026 (USD Million)
  12. Latin America Cancer Biomarkers Market, By Application, From 2021 to 2026 (USD Million)
  13. Latin America Risk Assessment Market, By Region, From 2021 to 2026 (USD Million)
  14. Latin America Development of molecular diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  15. Latin America Disease diagnosis Market, By Region, From 2021 to 2026 (USD Million)
  16. Latin America Drug discovery  Market, By Region, From 2021 to 2026 (USD Million)
  17. Latin America Development and Drug formulation Market, By Region, From 2021 to 2026 (USD Million)
  18. Latin America Cancer Biomarkers Market, By Type, From 2021 to 2026 (USD Million)
  19. Latin America Protein Biomarkers Market, By Region, From 2021 to 2026 (USD Million)
  20. Latin America Genetic biomarkers  Market, By Region, From 2021 to 2026 (USD Million)
  21. Latin America Other biomarkers Market, By Region, From 2021 to 2026 (USD Million)
  22. Latin America Cancer Biomarkers Market, By Profiling Technologies , From 2021 to 2026 (USD Million)
  23. Latin America Omics technologies  Market, By Region, From 2021 to 2026 (USD Million)
  24. Latin America Imaging technologies Market, By Region, From 2021 to 2026 (USD Million)
  25. Latin America Immunoassays Market, By Region, From 2021 to 2026 (USD Million)
  26. Latin America Cytogenetics Market, By Region, From 2021 to 2026 (USD Million)
  27. Latin America Bioinformatics Market, By Region, From 2021 to 2026 (USD Million)
  28. Latin America IVD multivariate index assays Market, By Region, From 2021 to 2026 (USD Million)
  29. Brazil Cancer Biomarkers Market, By Disease, From 2021 to 2026 (USD Million)
  30. Brazil Cancer Biomarkers Market, By Services, From 2021 to 2026 (USD Million)
  31. Brazil Cancer Biomarkers Market, By Application, From 2021 to 2026 (USD Million)
  32. Brazil Cancer Biomarkers Market, By Type, From 2021 to 2026 (USD Million)
  33. Brazil Cancer Biomarkers Market, By Profiling Technologies , From 2021 to 2026 (USD Million)
  34. Argentina Cancer Biomarkers Market, By Disease, From 2021 to 2026 (USD Million)
  35. Argentina Cancer Biomarkers Market, By Services, From 2021 to 2026 (USD Million)
  36. Argentina Cancer Biomarkers Market, By Application, From 2021 to 2026 (USD Million)
  37. Argentina Cancer Biomarkers Market, By Type, From 2021 to 2026 (USD Million)
  38. Argentina Cancer Biomarkers Market, By Profiling Technologies , From 2021 to 2026 (USD Million)
  39. Mexico Cancer Biomarkers Market, By Disease, From 2021 to 2026 (USD Million)
  40. Mexico Cancer Biomarkers Market, By Services, From 2021 to 2026 (USD Million)
  41. Mexico Cancer Biomarkers Market, By Application, From 2021 to 2026 (USD Million)
  42. Mexico Cancer Biomarkers Market, By Type, From 2021 to 2026 (USD Million)
  43. Mexico Cancer Biomarkers Market, By Profiling Technologies , From 2021 to 2026 (USD Million)
  44. Rest of Latin America Cancer Biomarkers Market, By Disease, From 2021 to 2026 (USD Million)
  45. Rest of Latin America Cancer Biomarkers Market, By Services, From 2021 to 2026 (USD Million)
  46. Rest of Latin America Cancer Biomarkers Market, By Application, From 2021 to 2026 (USD Million)
  47. Rest of Latin America Cancer Biomarkers Market, By Type, From 2021 to 2026 (USD Million)
  48. Rest of Latin America Cancer Biomarkers Market, By Profiling Technologies , From 2021 to 2026 (USD Million)
  49. Latin America Cancer Biomarkers Market, By Omics technologies, From 2021 to 2026 (USD Million)
  50. Latin America Genomics Market, By Region, From 2021 to 2026 (USD Million)
  51. Latin America Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  52. Latin America Metabolomics Market, By Region, From 2021 to 2026 (USD Million)
  53. Latin America Transcriptomics Market, By Region, From 2021 to 2026 (USD Million)
  54. Latin America Pharmacogenomics Market, By Region, From 2021 to 2026 (USD Million)
  55. Brazil Cancer Biomarkers Market, By Omics technologies, From 2021 to 2026 (USD Million)
  56. Argentina Cancer Biomarkers Market, By Omics technologies, From 2021 to 2026 (USD Million)
  57. Mexico Cancer Biomarkers Market, By Omics technologies, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample